Sansure Biotech Inc. (688289-SS) Stock Split, History Data
Working capital analysis
In terms of working capital, Sansure Biotech Inc. maintains a healthy position.
The total current assets of the company are valued at $5949593915.
This represents a growth rate of -20.940% compared to the previous year.
Breaking down the current assets, the cash and investments are worth $4233487649, exhibiting a growth rate of 31.778% year-on-year.
The receivables, another significant portion of the current assets, are valued at $732750836.
The year-on-year growth rate for receivables is -50.246%.
The inventory, which forms a critical part of the assets, is valued at $376632763.
This represents a healthy year-on-year growth of 6.000%
On the liabilities side, the company's current liabilities total $919152867.
This reflects a growth rate of -41.520% over the previous year, indicating the company's financial obligations are well under control.
2023
2022
2021
2020
2019
2018
Cash and investments
4233.49
3212.59
2636.22
2590.80
99.17
127.01
Receavebles
732.75
1472.74
894.07
606.70
195.60
171.06
Inventory
376.63
355.31
369.50
276.74
64.66
55.90
Other
58.44
33.59
19.97
7.25
11.45
5.14
Total Current Assets
5949.59
7525.44
5966.22
5082.70
437.20
359.11
Acc Payable
468.65
791.41
258.70
272.27
35.26
42.55
Short Term Debt
77.23
14.26
8.49
55.00
6.61
0.00
Other Current Liab
340.46
712.94
2.39
3.33
38.10
102.63
Current Liabilities
919.15
1571.73
663.93
688.69
73.36
145.18
Capital Structure
When examining the capital structure of Sansure Biotech Inc., it is clear that the company manages a robust portfolio.
These earnings represent the profits that Sansure Biotech Inc. has chosen to reinvest in the business rather than distribute as dividends.
